Potential drawbacks of SARS-CoV-2 seroprevalence surveys
- PMID: 33358929
- PMCID: PMC7834203
- DOI: 10.1016/j.jhin.2020.12.011
Potential drawbacks of SARS-CoV-2 seroprevalence surveys
Comment on
-
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16. J Hosp Infect. 2021. PMID: 33212126 Free PMC article.
References
-
- Bohn M.K., Loh T.P., Wang C.B., Mueller R., Koch D., Sethi S. IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2. Clin Chem Lab Med. 2020;58:2001–2008. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous